Safety and efficacy of anti-PD1 therapy for metastatic melanoma and non-small cell lung cancer in patients with concurrent viral hepatitis

被引：0
|
作者：
Kothapalli, A. [1 ]
Khattak, M. [2 ]
机构：
[1] Fiona Stanley Hosp, Dermatol, Perth, WA, Australia
[2] Fiona Stanley Hosp, Med Oncol, Perth, WA, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2018年 / 59卷
关键词：
PEMBROLIZUMAB; IPILIMUMAB;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] Therapy of Metastatic Non-small Cell Lung Cancer
    Reinmuth, N.
    Groeschel, A.
    Schumann, C.
    Sebastian, M.
    Wiewrodt, R.
    Reck, M.
    PNEUMOLOGIE, 2016, 70 (09): : 567 - 578
  • [42] Predictive immunological markers of anti-PD-1/PD-L1 therapy efficacy in non-small cell lung cancer
    Musaelyan, A. A.
    Lapin, S. V.
    Urtenova, M. A.
    Chistyakov, I. V.
    Nazarov, V. D.
    Akopov, A. L.
    Orlov, S. V.
    ANNALS OF ONCOLOGY, 2021, 32 : S1382 - S1382
  • [43] Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer
    Yin, Limei
    Xue, Jianxin
    Li, Rui
    Zhou, Lin
    Deng, Lei
    Chen, Lin
    Zhang, Yan
    Li, Yanying
    Zhang, Xuanwei
    Xiu, Weigang
    Tong, Ruizhan
    Gong, Youling
    Huang, Meijuan
    Xu, Yong
    Zhu, Jiang
    Yu, Min
    Li, Mengqian
    Lan, Jie
    Wang, Jin
    Mo, Xianming
    Wei, Yuquan
    Niedermann, Gabriele
    Lu, You
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (01): : 212 - 224
  • [44] Safety and efficacy of PD-1 inhibitors in non-small cell lung cancer patients positive for antinuclear antibodies
    Yoneshima, Yasuto
    Tanaka, Kentaro
    Shiraishi, Yoshimasa
    Hata, Kojiro
    Watanabe, Hiroyuki
    Harada, Taishi
    Otsubo, Kohei
    Iwama, Eiji
    Inoue, Hiroyuki
    Masuda, Satohiro
    Nakanishi, Yoichi
    Okamoto, Isamu
    LUNG CANCER, 2019, 130 : 5 - 9
  • [45] Efficacy and safety of apatinib monotherapy in elderly patients with advanced metastatic non-small cell lung cancer
    Li, Jian
    Tong, Xiwen
    Li, Hongtao
    INDIAN JOURNAL OF CANCER, 2020, 57 (01) : 13 - 17
  • [46] Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
    Velez, Michel
    Arango, Belisario A.
    Perez, Cesar A.
    Santos, Edgardo S.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 117 - 124
  • [47] Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
    Banna, Giuseppe Luigi
    Cantale, Ornella
    Bersanelli, Melissa
    Del Re, Marzia
    Friedlaender, Alex
    Cortellini, Alessio
    Addeo, Alfredo
    ONCOLOGY REVIEWS, 2020, 14 (02) : 135 - 143
  • [48] Efficacy and safety of PD-1/PD-L1 inhibitors in elderly patients with advanced non-small cell lung cancer
    Li, Li
    Xu, Chunhua
    Wang, Wei
    Zhang, Qian
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (05):
  • [49] Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients
    Nakamura, Yukiko
    Miyazaki, Kazuhito
    Aiko, Naoto
    Misumi, Yuki
    Agemi, Yoko
    Taniguchi, Yuri
    Ishi, Mari
    Shimokawa, Tsuneo
    Okamoto, Hiroaki
    Yamanaka, Takeharu
    ANTICANCER RESEARCH, 2020, 40 (02) : 923 - 928
  • [50] High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
    Kim, Hak Su
    Kwon, Seung-hyun
    Choi, Ok Kyung
    Lim, Taekyu
    FRONTIERS IN IMMUNOLOGY, 2025, 15
12345